Skip to main content
logo
MediPal Holdings Corporation (TYO:7459)
Japan flag Japan · Delayed Price · Currency is JPY
3,387.00
+181.00 (5.65%)
Oct 26, 2026, 3:24 PM JST

MediPal Holdings Financials Overview

Millions JPY. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
3,861,6983,817,3543,671,3283,558,7323,360,0083,290,921
Revenue Growth
4.17%3.98%3.16%5.91%2.10%2.48%
Gross Profit
262,043260,988255,759246,655224,305217,445
Operating Income
52,51353,18455,61147,33148,97445,625
Net Income
46,59442,53440,27941,47438,80629,423
Earnings Per Share
227.21206.67193.19195.83179.12131.41
EPS Growth
15.65%6.98%-1.35%9.33%36.31%23.04%

Revenue by Segment
Chart
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cosmetics, Daily Necessities, and Over-The-Counter Pharmaceutical Wholesale Business
1,248,7261,237,8461,188,0971,151,9661,104,1521,045,735
Businesses Related to the Wholesale of Veterinary Drugs and Raw Materials for Food Processing
120,319117,328116,861114,02373,95471,858
Wholesale Business of Medical Pharmaceuticals and Related Products
2,496,6642,466,1092,370,2452,295,7952,189,6672,177,002
Unallocated Adjustment
-4,011-3,930-3,876-3,051-7,766-3,675
Total
3,861,6983,817,3533,671,3273,558,7333,360,0073,290,920

Cash & Debt
Chart
Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
289,923289,073261,407230,470195,031261,920
Total Debt
-----30,078
Net Cash (Debt)
289,923289,073261,407230,470195,031231,842
Net Cash Growth
17.84%10.58%13.42%18.17%-15.88%9.91%
Net Cash Per Share
1413.761404.601253.811088.23901.481039.08

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-46,55260,55961,84316,14661,216
Capital Expenditures
--6,619-8,861-15,560-10,483-15,958
Free Cash Flow
-39,93351,69846,2835,66345,258
Free Cash Flow Growth
--22.76%11.70%717.29%-87.49%109.47%

Margins
Chart
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
6.79%6.84%6.97%6.93%6.68%6.61%
Operating Margin
1.36%1.39%1.52%1.33%1.46%1.39%
Pretax Margin
2.25%2.14%2.09%2.10%2.09%1.74%
Profit Margin
1.21%1.11%1.10%1.17%1.16%0.89%
FCF Margin
-1.05%1.41%1.30%0.17%1.38%

Dividends
Chart
Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingOct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Dividend Per Share
88.00066.00062.00060.00046.00044.000
Dividend Per Share Growth
21.88%6.45%3.33%30.44%4.54%4.76%
Dividend Yield
2.60%2.25%2.66%2.59%2.55%2.18%

Valuation
Chart
Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingOct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
14.9114.1412.0611.759.7614.38
Forward PE
12.8915.8013.3613.8712.1513.42
P/FCF Ratio
16.4315.069.3910.5366.899.35
PS Ratio
0.170.160.130.140.110.13